BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 32620549)

  • 1. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.
    Ianiro G; Mullish BH; Kelly CR; Kassam Z; Kuijper EJ; Ng SC; Iqbal TH; Allegretti JR; Bibbò S; Sokol H; Zhang F; Fischer M; Costello SP; Keller JJ; Masucci L; van Prehn J; Quaranta G; Quraishi MN; Segal J; Kao D; Satokari R; Sanguinetti M; Tilg H; Gasbarrini A; Cammarota G
    Gut; 2020 Sep; 69(9):1555-1563. PubMed ID: 32620549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
    Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
    Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study.
    Ianiro G; Bibbò S; Masucci L; Quaranta G; Porcari S; Settanni CR; Lopetuso LR; Fantoni M; Sanguinetti M; Gasbarrini A; Cammarota G
    Dig Liver Dis; 2020 Dec; 52(12):1390-1395. PubMed ID: 33004295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
    Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
    PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
    Cammarota G; Ianiro G; Kelly CR; Mullish BH; Allegretti JR; Kassam Z; Putignani L; Fischer M; Keller JJ; Costello SP; Sokol H; Kump P; Satokari R; Kahn SA; Kao D; Arkkila P; Kuijper EJ; Vehreschild MJG; Pintus C; Lopetuso L; Masucci L; Scaldaferri F; Terveer EM; Nieuwdorp M; López-Sanromán A; Kupcinskas J; Hart A; Tilg H; Gasbarrini A
    Gut; 2019 Dec; 68(12):2111-2121. PubMed ID: 31563878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
    Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT
    J Hosp Infect; 2024 Jun; 148():189-219. PubMed ID: 38609760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of faecal microbiota transplant as treatment for recurrent or refractory
    Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT
    Gut; 2024 Jun; 73(7):1052-1075. PubMed ID: 38609165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.
    Haifer C; Kelly CR; Paramsothy S; Andresen D; Papanicolas LE; McKew GL; Borody TJ; Kamm M; Costello SP; Andrews JM; Begun J; Chan HT; Connor S; Ghaly S; Johnson PD; Lemberg DA; Paramsothy R; Redmond A; Sheorey H; van der Poorten D; Leong RW
    Gut; 2020 May; 69(5):801-810. PubMed ID: 32047093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
    Khanna S; Tande A; Rubin DT; Khoruts A; Kahn SA; Pardi DS
    Mayo Clin Proc; 2021 Jun; 96(6):1418-1425. PubMed ID: 34088413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation.
    Vindigni SM; Surawicz CM
    Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic.
    Kazemian N; Kao D; Pakpour S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for rational donor selection in fecal microbiota transplant clinical trials.
    Duvallet C; Zellmer C; Panchal P; Budree S; Osman M; Alm EJ
    PLoS One; 2019; 14(10):e0222881. PubMed ID: 31600222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of SARS-CoV-2 and
    Khanna S; Kraft CS
    Future Microbiol; 2021 Apr; 16():439-443. PubMed ID: 33847139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
    Khanna S; Pardi D
    Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of Endoscopy in Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.
    Navaneethan U; Lourdusamy D; LehnerNoguera V; Shen B
    Inflamm Bowel Dis; 2020 Sep; 26(10):e118-e119. PubMed ID: 32676646
    [No Abstract]   [Full Text] [Related]  

  • 17. Fecal testing for SARS-CoV-2 in patients undergoing elective lower gastrointestinal endoscopy is advised.
    Hamid HKS
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1452. PubMed ID: 32372533
    [No Abstract]   [Full Text] [Related]  

  • 18. How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic: A sound transplant protection strategy.
    Lauterio A; De Carlis R; Belli L; Fumagalli R; De Carlis L
    Transpl Int; 2020 Aug; 33(8):969-970. PubMed ID: 32348586
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving Risk-Benefit in Faecal Transplantation through Microbiome Screening.
    Papanicolas LE; Gordon DL; Wesselingh SL; Rogers GB
    Trends Microbiol; 2020 May; 28(5):331-339. PubMed ID: 31952909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Faecal microbiota transplantation for the treatment of bowel disease].
    Rode AA; Chehri M; Petersen AM; Bytzer P
    Ugeskr Laeger; 2017 Jul; 179(31):. PubMed ID: 28869008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.